John T. Burns's most recent trade in SELLAS Life Sciences Group Inc was a trade of 169,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 10, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
SELLAS Life Sciences Group... | John T. Burns | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 169,500 | 169,500 | - | - | Stock Option (Right to Buy) | |
SELLAS Life Sciences Group... | John T. Burns | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 113,000 | 217,762 (4%) | 2% | 0 | Common Stock | |
SELLAS Life Sciences Group... | John T. Burns | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 81,300 | 299,062 (5%) | 1% | 0 | Common Stock | |
SELLAS Life Sciences Group... | Burns John T. | CFO | Other type of transaction at price $ 1.13 per share. | 04 Dec 2024 | 7,165 | 104,762 (2%) | 0% | 1.1 | 8,096 | Common Stock |
SELLAS Life Sciences Group... | Burns T. John | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
SELLAS Life Sciences Group... | John T. Burns | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 47,000 | 101,927 (2%) | 0% | 0 | Common Stock | |
SELLAS Life Sciences Group... | John T. Burns | CFO | Other type of transaction at price $ 1.08 per share. | 06 Dec 2023 | 2,929 | 54,927 (1%) | 0% | 1.1 | 3,163 | Class A Common Stock |
SELLAS Life Sciences Group... | John T. Burns | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 75,000 | 75,000 | - | - | Stock Option Right to Buy) | |
SELLAS Life Sciences Group... | John T. Burns | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 20,000 | 49,347 (0%) | 0% | 0 | Common Stock | |
SELLAS Life Sciences Group... | John T. Burns | Senior VP, Finance & CAO | Sale of securities on an exchange or to another person at price $ 2.59 per share. | 05 Dec 2022 | 1,159 | 29,347 (0%) | 0% | 2.6 | 3,002 | Class A Common Stock |
SELLAS Life Sciences Group... | John T. Burns | Senior VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
SELLAS Life Sciences Group... | John T. Burns | Senior VP, Finance & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 9,600 | 27,244 (0%) | 0% | 0 | Common Stock |